129 related articles for article (PubMed ID: 4895860)
1. Can LATS be detected by immunofluorescence?
Beall GN; Solomon DH; Doniach D; Roitt IM
J Clin Endocrinol Metab; 1969 Aug; 29(8):1114-6. PubMed ID: 4895860
[No Abstract] [Full Text] [Related]
2. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
[No Abstract] [Full Text] [Related]
3. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
[No Abstract] [Full Text] [Related]
4. What is the antibody specificity of LATS?
Fagraeus A; Jonsson J; el-Kabir DJ
J Clin Endocrinol Metab; 1970 Oct; 31(4):445-7. PubMed ID: 4916544
[No Abstract] [Full Text] [Related]
5. Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders.
Mori T; Kriss JP
J Clin Endocrinol Metab; 1971 Oct; 33(4):688-98. PubMed ID: 5109861
[No Abstract] [Full Text] [Related]
6. LATS and thyroid autoantibodies.
Beall GN; Solomon DH
Clin Exp Immunol; 1968 Sep; 3(7):615-9. PubMed ID: 4883066
[TBL] [Abstract][Full Text] [Related]
7. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
[TBL] [Abstract][Full Text] [Related]
8. Failure to detect long-acting thyroid stimulator with the immunofluorescence technique.
Fedder G; Feltkamp TE
Clin Exp Immunol; 1970 Jan; 6(1):167-8. PubMed ID: 4906525
[No Abstract] [Full Text] [Related]
9. [Immunological problems in thyroid diseases].
Müller W
Med Klin; 1969 Aug; 64(34):1487-92. PubMed ID: 4900624
[No Abstract] [Full Text] [Related]
10. [Demonstration of antithyroid antibodies with a passive hemagglutination test using glutaraldehyde as coupling agent].
Tribouley J; Capbern A; Bezian JH
C R Acad Hebd Seances Acad Sci D; 1971 Mar; 272(10):1462-4. PubMed ID: 4994991
[No Abstract] [Full Text] [Related]
11. [Evaluation of the study of thyroid autoantibodies by indirect immunofluorescence in 317 individuals. Histopathological comparison in 102 cases].
Codaccioni JL; Depieds R; Jean R; Henry C; Lebreuil G
Ann Endocrinol (Paris); 1971; 32(1):172-82. PubMed ID: 4933677
[No Abstract] [Full Text] [Related]
12. Specific and nonspecific responses in the bioassay of long-acting thyroid stimulator (LATS).
Chopra IJ; Solomon DH; Limberg NP
J Clin Endocrinol Metab; 1970 Oct; 31(4):382-90. PubMed ID: 5468701
[No Abstract] [Full Text] [Related]
13. Immunological studies on human thyroid glands, especially on antigenicity of epithelial cells in various diseases.
Kawamura N
Bull Tokyo Med Dent Univ; 1969 Dec; 16(4):311-25. PubMed ID: 4192196
[No Abstract] [Full Text] [Related]
14. Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration of migration inhibition factor (MIF).
Lamki L; Row VV; Volpé R
J Clin Endocrinol Metab; 1973 Feb; 36(2):358-64. PubMed ID: 4739173
[No Abstract] [Full Text] [Related]
15. [Humoral antibodies and cellular immune mechanisms in various thyroid diseases and their relation to the clinical feature (author's transl)].
Helmke K; Federlin K
Klin Wochenschr; 1974 Jun; 52(12):578-88. PubMed ID: 4603584
[No Abstract] [Full Text] [Related]
16. [The clinical significance of thyroid autoantibodies].
Fellinger K; Höfer R; Schatz H; Meister F
Wien Z Inn Med; 1965 Sep; 46(9):345-50. PubMed ID: 5899218
[No Abstract] [Full Text] [Related]
17. Relationship of long-acting thyroid stimulator to pretibial myxedema.
Schermer DR; Roenigk HH; Schumacher OP; McKenzie JM
Arch Dermatol; 1970 Jul; 102(1):62-7. PubMed ID: 4925011
[No Abstract] [Full Text] [Related]
18. LATS protector, the human thyroid stimulator.
Adams DD
N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
[No Abstract] [Full Text] [Related]
19. Changes in LATS and other thyoid autoantibody levels with therapy.
Kilpatrick JA
N Z Med J; 1974 Dec; 80(529):495-6. PubMed ID: 4532201
[No Abstract] [Full Text] [Related]
20. Leucocyte migration inhibition with mitochondria in human autoimmune thyroid disorders.
Wartenberg J; Doniach D; Brostoff J; Roitt IM
Clin Exp Immunol; 1973 Jun; 14(2):203-12. PubMed ID: 4740446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
